10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0001144204-18-028882`
Period End Date	20180331
Filing Date	20180515
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	bpth-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 20 Cash Flow Statement 34

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$5.96M	USD	Point-in-time
Cash	`Cash`	$4.28M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$9.38M	USD	Point-in-time
Cash	`Cash`	$7.11M	USD	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$1.12M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$1.26M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$330.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$353.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.87M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.43M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	11.34M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	11.34M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	11.34M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$984.00K	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.00M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	11.34M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$330.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$396.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$605.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$654.00K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.77M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.73M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$769.00K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$729.00K	USD	Point-in-time
Total Assets	`Assets`	$8.86M	USD	Point-in-time
Total Assets	`Assets`	$7.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$52.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$136.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$793.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$739.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$929.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$791.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$791.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$929.00K	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 11,341 and 11,339 shares issued and outstanding, respectively	`CommonStockValue`	$11.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 11,341 and 11,339 shares issued and outstanding, respectively	`CommonStockValue`	$11.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$47.21M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$47.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-41.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-39.16M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$6.28M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.07M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$7.20M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$8.86M	USD	Point-in-time

Income Statement 20 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$932.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.03M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$970.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$987.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.92M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.92M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.00M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.60M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.60M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$3.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.92M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-397.00K	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.17	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.34M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.56M	shares	1 Quarter

Cash Flow Statement 34 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.92M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-397.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$40.00K	USD	1 Quarter
Depreciation	`Depreciation`	$66.00K	USD	1 Quarter
Depreciation	`Depreciation`	$33.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$249.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$124.00K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.60M	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$1.00K	USD	1 Quarter
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$139.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-40.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-23.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-208.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$138.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.66M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.84M	USD	1 Quarter
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$424.00K	USD	1 Quarter
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$17.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-424.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.00K	USD	1 Quarter
Net decrease in cash	`CashPeriodIncreaseDecrease`	$-1.68M	USD	1 Quarter
Net decrease in cash	`CashPeriodIncreaseDecrease`	$-2.26M	USD	1 Quarter
Cash, beginning of period	`Cash`	$5.96M	USD	Point-in-time
Cash, beginning of period	`Cash`	$4.28M	USD	Point-in-time
Cash, beginning of period	`Cash`	$9.38M	USD	Point-in-time
Cash, beginning of period	`Cash`	$7.11M	USD	Point-in-time
Cash, end of period	`Cash`	$5.96M	USD	Point-in-time
Cash, end of period	`Cash`	$4.28M	USD	Point-in-time
Cash, end of period	`Cash`	$9.38M	USD	Point-in-time
Cash, end of period	`Cash`	$7.11M	USD	Point-in-time
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$114.00K	USD	1 Quarter
Capital expenditures included in accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.